- This event has passed.
Open Call P4 Precision Medicine Accelerator Programme
P4 Precision Medicine Accelerator Programme – The program seeks the world’s leading Precision Medicine startups to support development, regulation, investment, adoption, and scale to the UK and international markets to innovate and advance the healthcare landscape. London, UK; Deadline – October 31, 2020
The program curates an ecosystem of physical space and specialist to support precision medicine innovations to develop research into world-leading technology, support to gain regulatory approval and adoption not only to the UK healthcare system but scale internationally.
The program is led by Professor Phil Beales, Chair of the UCL Institute of Precision Medicine, Professor of Medical and Molecular Genetics at the UCL Great Ormond Street Institute of Child Health and UCLPartners. The delivery of precision medicine requires several sectors (academia, healthcare, and industry) to work together. Our mission is to facilitate new and innovative collaborations with academia, industry, and healthcare by creating the P4 program.
UCL has partnered with Capital Enterprise, a body of connectors, influencers, investors, and policy-makers, collaborating to serve and super-charge London’s start-up scene.
The P4 program creates a new and unique ecosystem to facilitate the scale and adoption of precision medicine SMEs by providing access to unparalleled expertise in genomic profiling, drug targeting, disease marker discovery, diagnostics/companion diagnostics, clinical trials design and delivery, software development, engineering, artificial intelligence, regulatory compliance, and health data. Cross-faculty support led by the UCL Institute for Precision Medicine leverages the talent pool of academics at UCL and its partners. Capital Enterprise has experience supporting and scaling tech SMEs and providing access to unique funding streams to ensure SMEs thrive.